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Review of the immunoglobulin light chain variable region sequences from multiple myeloma cells
TO THE EDITOR
We are grateful to Drs Kosmas and Stamatopoulos for their constructive remarks about our paper. 1 Although they suggested that our data should be discussed in relation to the recently published studies, [2] [3] [4] most of them, unfortunately, were not available when we submitted this manuscript. As suggested by them, the most important difference with the published sequences is N-nucleotide insertion in V -J junctions. We found possible N region in four V -J junctions. The V and J genes from patient DL3 had no homology at the 3′ end and 5′ end, respectively, 27 nucleotides at the V -J junctions were tentatively assigned as an N region. Since we could not determine the exact germline sequence in each patient, and the N regions found in the V -J junctions consisted of only one or two nucleotides, these might be caused from polymorphism at the 3′ and 5′ ends of V and J gene, respectively. To solve this issue, further analyses based on the comparison with the exact germline of each patient are required.
In our study, there are four IgD myeloma cases. As suggested by Drs Kosmas and Stamatopoulos, an incidence is much higher than that of all clinical series. However, our cohort of patients analyzed was not sequential. It so happened that the available samples contained many IgD myeloma cases. They further pointed out that our study includes three IgD/ myeloma cases, resulting in the higher mutation rate in the V gene. Indeed, one patient (DL1) had extensive mutations in the V gene, even if compared with the most homologous published germline. As described in the paper, this mutation rate was so high that we did not include this case for further analyses. Furthermore, mutation rates of the other V genes from IgD/ myeloma cases were within the standard deviation of all V genes.
Somatic mutations contribute to the diversification of the rearranged Ig genes and are important for affinity maturation during B cell development. Somatic mutations in the J region were frequently found in most B cell malignancies. The mean mutation rate of the J gene was significantly higher than that of the J genes. It is not clear why mutations were more frequently observed in the J genes than in the J genes. After reanalyzing our sequence data, the mutations of the J gene were found to be highly clustered in the restricted nucleotides (ie the third letter of V97, the third letter of G100 and the first letter of L104). These data suggested a possibility that polymorphism was mistaken for mutations.
The total mutation rate in the IgL chain variable region gene from our myeloma cases ranged from 2.7 to 34.1%, if compared with the most homolgous published germlines. As described in the paper, we tentatively calculated the mutation rate by comparing with the most homologous germline genes. We believe two V region genes from AK6 and DL1 are derived from novel V genes. Souther blot analysis using placenta DNA and these V genes as probe showed several bands, supporting our hypothesis.
We can accept the opinion that the binomial probability model should be applied for evaluating the distribution of Rmutations. 5 Here, we show the distribution of mutations in the V and V genes of our myeloma cases (Table 1 ). Significant clustering of R mutations in CDRs occurred in 3/16 (18.8%) V genes and 3/15 (20%) V genes. Dr Kosmas et al reported that this was observed in 6/11 (55%) V genes and 2/6 (20%) V genes. 4 Although there seem to be differences between the two studies, analyzed sequences were too few to solve this issue. In addition, significant clustering of R-mutations in CDRs preferentially occurred in V 1 genes (6/6 in their study and 2/3 in our study). To determine whether this clustering preferentially occurred in V 1 genes or equally in all V genes, further analysis is required. However, we can conclude that the nature of the myeloma progenitors is heterogeneous, and that a proportion of myeloma cells originated from the B cell populations which already received antigen-derived selections.
In conclusion, we essentially accept the suggestion of Drs Kosmas and Stamatopoulos. However, since both they and we compared the sequence data with the most homologous published germline gene, not with the exact germline of each patient, statistical analysis should be handled carefully.
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Note added in proof
Recently, Farner et al 6 found N-nucleotide insertions at 71% of the productive V-J junctions in peripheral B cells.
